Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Transl Lung Cancer Res. 2019 Dec;8(6):886-894. doi: 10.21037/tlcr.2019.11.16.
Transl Lung Cancer Res. 2019.
PMID: 32010567
Free PMC article.
Clinical data was sourced from Calvary Mater Newcastle between 2010 and 2015. RESULTS: Baseline NLR, PLR, LMR and ALI showed strong association with OS. Five unit increase in NLR and PLR was associated with an 11% and 0.5% increase in the hazard of death respectively while …
Clinical data was sourced from Calvary Mater Newcastle between 2010 and 2015. RESULTS: Baseline NLR, PLR, LMR and ALI showed strong a …